Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Releases Earnings Results, Misses Expectations By $0.01 EPS

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) issued its quarterly earnings data on Monday. The company reported ($0.50) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.49) by ($0.01), FiscalAI reports. The firm had revenue of $19.56 million during the quarter. Senseonics Holdings, Inc. Common Stock had a negative return on equity of 197.93% and a negative net margin of 204.01%.

Here are the key takeaways from Senseonics Holdings, Inc. Common Stock’s conference call:

• Q3 revenue more than doubled year over year to a record $19.6 million, led by U.S. growth of about 160%. Senseonics raised 2026 revenue guidance for the third time, to $68 million–$70 million from $62 million–$66 million.
• Commercial indicators were strong: the company reported record new patient starts, active prescribers increased more than 90% year over year, and about nine in 10 new insertions came from patients switching from competing sensors. Management said reorder rates are ahead of plan.
• Senseonics expects to launch its Eversense 365 integration with Beta Bionics’ iLet system in the coming weeks, adding to its existing Sequel/twiist partnership. Management said it expects to be a $100 million revenue company in 2027, though formal guidance will come early next year.
• The company began human testing of Freedom, a planned CGM with no on-body component, and is targeting a pivotal study in 2027 and potential launch in 2028. These remain forward-looking milestones; the current study is an early-feasibility evaluation.
• Despite gross margin improving to about 62%, Q3 net loss widened to $32.7 million from $19.5 million a year earlier. Full-year operating expenses are expected to be slightly above the prior $150 million–$160 million range, and cash utilization is forecast at about $120 million; management expects cash-flow breakeven shortly after Freedom launches.

Senseonics Holdings, Inc. Common Stock Stock Performance

Shares of Senseonics Holdings, Inc. Common Stock stock traded up $0.27 during midday trading on Wednesday, hitting $10.30. The company had a trading volume of 277,101 shares, compared to its average volume of 685,789. The business’s 50 day simple moving average is $9.13 and its two-hundred day simple moving average is $7.28. The stock has a market cap of $430.71 million, a PE ratio of -4.45 and a beta of 1.04. The company has a debt-to-equity ratio of 0.62, a current ratio of 6.74 and a quick ratio of 6.40. Senseonics Holdings, Inc. Common Stock has a 1-year low of $4.79 and a 1-year high of $13.98.

Insider Buying and Selling

In related news, Director Douglas Roeder bought 13,953 shares of the business’s stock in a transaction that occurred on Wednesday, August 19th. The stock was purchased at an average cost of $8.98 per share, for a total transaction of $125,297.94. Following the purchase, the director directly owned 171,191 shares in the company, valued at $1,537,295.18. This trade represents a 8.87% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 4.70% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Ieq Capital LLC bought a new stake in shares of Senseonics Holdings, Inc. Common Stock in the third quarter valued at about $215,000. StoneX Group Inc. bought a new position in Senseonics Holdings, Inc. Common Stock during the third quarter valued at about $128,000. Traynor Capital Management Inc. bought a new position in Senseonics Holdings, Inc. Common Stock during the third quarter valued at about $152,000. State of Wyoming raised its holdings in Senseonics Holdings, Inc. Common Stock by 27.2% in the 3rd quarter. State of Wyoming now owns 14,940 shares of the company’s stock valued at $152,000 after acquiring an additional 3,199 shares in the last quarter. Finally, Integrated Wealth Concepts LLC acquired a new position in Senseonics Holdings, Inc. Common Stock in the 2nd quarter valued at approximately $36,000. Institutional investors own 12.36% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on SENS. Barclays lifted their target price on shares of Senseonics Holdings, Inc. Common Stock from $10.00 to $11.00 and gave the stock an “equal weight” rating in a report on Tuesday. Wall Street Zen upgraded shares of Senseonics Holdings, Inc. Common Stock from a “strong sell” rating to a “sell” rating in a report on Saturday, August 8th. Weiss Ratings raised Senseonics Holdings, Inc. Common Stock from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, November 4th. Mizuho raised their price target on Senseonics Holdings, Inc. Common Stock from $18.00 to $20.00 and gave the company an “outperform” rating in a research report on Tuesday. Finally, Stifel Nicolaus reiterated a “hold” rating and issued a $10.00 price objective (up from $9.00) on shares of Senseonics Holdings, Inc. Common Stock in a research note on Tuesday. Three analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $14.40.

Trending Headlines about Senseonics Holdings, Inc. Common Stock

Here are a few of the latest headlines about SENS:

• Positive Sentiment: Third-quarter revenue rose about 140% year over year to $19.6 million and beat estimates. Senseonics raised its 2026 revenue outlook to $68 million–$70 million, above its prior $62 million–$66 million range and the $64.2 million consensus. It also reported roughly 62% quarterly gross margin and raised its full-year gross-margin outlook to more than 60%. Third-quarter 2026 results
• Positive Sentiment: Several analysts lifted price targets: Mizuho raised its target to $20 and kept an outperform rating, while TD Cowen raised its target to $17 and maintained buy. HC Wainwright also reiterated buy with a $14 target. These revisions signal improved analyst expectations, though targets are not guarantees. Mizuho recommendations TD Cowen recommendations HC Wainwright recommendations
• Neutral Sentiment: Raymond James upgraded SENS from underperform to market perform, while Barclays and Stifel maintained more cautious stances. A report also said the shares moved above their 50-day moving average, a potentially supportive technical signal. Stock moves above 50-day moving average

About Senseonics Holdings, Inc. Common Stock

Senseonics Holdings, Inc. is a medical technology company focused on developing and commercializing long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes. Its CGM technology is designed to measure glucose levels continuously through a small sensor inserted under the skin, with readings transmitted to an external smart transmitter and mobile application. The company’s primary product is the Eversense CGM system. Unlike many conventional CGM systems that use an externally worn sensor, Eversense uses an implantable sensor and a removable, rechargeable transmitter worn over the sensor site.